US20080175931A1 - Cosmetic foundation - Google Patents

Cosmetic foundation Download PDF

Info

Publication number
US20080175931A1
US20080175931A1 US11/899,773 US89977307A US2008175931A1 US 20080175931 A1 US20080175931 A1 US 20080175931A1 US 89977307 A US89977307 A US 89977307A US 2008175931 A1 US2008175931 A1 US 2008175931A1
Authority
US
United States
Prior art keywords
approximately
weight
foundation
total composition
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/899,773
Inventor
Nathalie Schlemer
Jennifer Di Marco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guthy-Renker Corp
Original Assignee
Guthy-Renker Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/655,420 external-priority patent/US20080175805A1/en
Application filed by Guthy-Renker Corp filed Critical Guthy-Renker Corp
Priority to US11/899,773 priority Critical patent/US20080175931A1/en
Assigned to GUTHY-RENKER CORPORATION reassignment GUTHY-RENKER CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DI MARCO, JENNIFER, SCHLEMER, NATHALIE
Priority to PCT/US2008/002148 priority patent/WO2009032022A1/en
Assigned to UNION BANK OF CALIFORNIA, N.A., AS ADMINISTRATIVE AGENT reassignment UNION BANK OF CALIFORNIA, N.A., AS ADMINISTRATIVE AGENT SECURITY AGREEMENT Assignors: GUTHY-RENKER LLC
Publication of US20080175931A1 publication Critical patent/US20080175931A1/en
Priority to US12/701,394 priority patent/US8252298B2/en
Priority to US13/597,154 priority patent/US20120321684A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12—Face or body powders for grooming, adorning or absorbing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A61K2800/436—Interference pigments, e.g. Iridescent, Pearlescent

Definitions

  • the present invention relates to cosmetic compositions and, in particular, to a cosmetic foundation.
  • Powder foundations which may come in a pressed or loose powder form, are well known cosmetics, and have been used for many years. Most powder and pressed powder foundations provide skin coverage and color enhancement for affecting the temporary look of the skin, and sun protection. Additionally, there is a constant need for improved cosmetics which provide various skin benefits and enhance the overall quality of the skin. Users of cosmetics such as foundations typically use other skin benefiting products, which they may apply either underneath the foundation, or at a time when the foundation is not worn, so as to not affect the functionality of the foundation. Hence, a foundation which improves the overall skin quality, while providing skin coverage, is highly desirable.
  • the present invention provides a cosmetic mineral foundation, which is a pressed powder, comprising unfermented green rooibos extract ( aspalathus linearis leaf) combined with stoechas lavender extract, ascorbyl palmitate, tocopheryl acetate, aloe barbadensis leaf juice and zinc oxide, which is preferably micronized.
  • Other ingredients may include boron nitride, zinc stearate, lauroyl lysine, octyldodecyl stearoyl stearate, caprylic/capric triglyceride, mica, bisabolol, and coloring agents preferably comprising titanium dioxide and iron oxide.
  • the foundation is gentle for all skin types, can be used daily, and provides significant skin benefits including antioxidant, anti-irritant, anti-microbial, anti-allergenic, and anti-aging benefits. It further helps reduce the appearance of fine lines and wrinkles, and diminish signs of aging caused by free-radical damage, as well as quality skin coverage. As such, it provides not just color enhancement, but also benefits the skin.
  • safe and effective amount means a sufficient amount of a compound, composition or other material described by this phrase to significantly induce a positive modification in the condition being treated, but low enough to avoid undue side effects (e.g., significant skin irritation or sensitization), within the scope of sound judgment of the skilled person.
  • the safe and effective amount of the compound, composition or other material may vary with the particular skin being treated, the age and physical condition of the biological subject being treated, the severity of the condition, the duration of treatment, the nature of concurrent therapy, the specific compound, composition, or other material employed, the particular cosmetically acceptable topical carrier utilized, and the factors within the knowledge and expertise of the skilled person.
  • the present invention provides a cosmetic foundation, which is a pressed mineral powder, comprising unfermented green rooibos extract ( aspalathus linearis leaf) combined with stoechas lavender extract, ascorbyl palmitate, tocopheryl acetate, aloe barbadensis leaf juice, bisabolol, and zinc oxide, which is preferably micronized.
  • Other ingredients may include boron nitride, zinc stearate, lauroyl lysine, octyldodecyl stearoyl stearate, caprylic/capric triglyceride, mica, and coloring agents preferably comprising titanium dioxide and iron oxide.
  • the foundation is gentle for all skin types, can be used daily, and provides significant skin benefits including antioxidant, anti-irritant, anti-microbial, anti-allergenic, and anti-aging benefits. It further helps reduce the appearance of fine lines and wrinkles, and diminish signs of aging caused by free-radical damage, as well as quality skin coverage.
  • Green rooibos extract is a natural botanical having anti-oxidant, anti-inflammatory/anti-irritant, and free radical scavenging properties, partly due to its unique flavonoid content which includes aspalathin. Additionally, it has high anti-allergenic and anti-microbial effects and further prevents eczema. Its properties are ascribed to the high level of antioxidants, minerals, and polyphenols. While its use in cosmetics is generally known, it is much more commonly used and known as an anti-oxidant tea, where it is typically used in its fermented form. The fermentation process normally starts naturally immediately after the plant is harvested. However, fermentation alters and reduces the flavonoid composition hence significantly reducing the anti-oxidant activity.
  • the antioxidant activity of the unfermented powdered extract has been found to be much higher than the usual rooibos extract which is fermented.
  • the mineral powder foundation of the present invention includes a safe and effective amount of unfermented green rooibos extract ( aspalathus linearis leaf), preferably at a concentration of approximately around up to 1% by weight, and more preferably at about 0.1% by weight.
  • Stoechas lavender extract works as an anti-aging agent. It is preferably formulated with caprylic/capric triglyceride under the trade name LavandoxTM, which is commercially available from Barnet Products®.
  • the foundation of the present invention includes a safe and effective amount of LavandoxTM, preferably at a concentration of approximately 0.1-3%, and more preferably at about 1.0%.
  • the formulation further includes a safe and effective amount of vitamins comprising ascorbyl palmitate and tocopheryl acetate, which are anti-oxidant.
  • the formulation preferably includes ascrobyl palmitate and tocopheryl acetate, each at a concentration of approximately 0.001-2% by weight, and more preferably at around 0.05%.
  • the formulation further includes aloe barbadensis leaf juice, which provides skin healing/soothing benefits, at a concentration of approximately 0.001 to 2%, and more preferably at around 0.02%.
  • the formulation further includes bisabolol, which acts as a skin soothing agent, at a concentration of approximately 0.01-1% by weight, and more preferably at around 0.1%.
  • the zinc oxide used in the present formulation is preferably micronized, having a particle size of preferably less than 0.2 microns, and more preferably, about less than 0.1 microns, which increase its sunscreening effectiveness and esthetics compared to larger particles.
  • the formulation of the present invention preferably uses zinc oxide at a concentration of roughly about 9-15% by weight, and more preferably at about 12%.
  • the formulation of the present invention may further include other ingredients such as slip agents, skin adhesion agents, binders, emollients, etc.
  • the preferred carrier ingredients of the present invention include boron nitride, at a concentration of approximately 2-15% by weight, and more preferably at around 5%, zinc stearate, at a concentration of approximately 2-15% by weight, and more preferably at around 5%, lauroyl lysine, at a concentration of approximately 0.2-1.5% by weight, and more preferably at around 0.5%, and octyldodecyl stearoyl stearate, at a concentration of approximately 2-15% by weight, and more preferably at around 5%.
  • the formulation further contains visual effect agents comprising mica, and colorants, which are preferably mineral colorants such as titanium dioxide and iron oxides.
  • concentrations of the visual effect agents will depend on the color shades and visual effects desired, and the particular agents used.
  • the concentrations may vary, between roughly about 40-85% by weight of total composition, and is preferably between 70-74%.
  • mineral colorants one skilled in the art may be able to use artificial colors to create a similar formulation.
  • the colorants described herein may vary depending on the manufacturer and desired color effect.
  • the foundation of the present invention is preferably made of natural botanicals and minerals, and preferably contains no preservatives, fragrances, dyes or chemicals, and oils, and is preferably formulated without fillers such as silicone, talc, and mineral oil. It is especially formulated for troubled and sensitive skin.
  • the inert minerals do not support bacterial growth.
  • the natural pigments do not pile on the edges of skin pores, which would make pores more visible. Additionally, the formulation is designed to deflect light away from skin imperfections, for a line minimizing effect.
  • Example 1-9 blend all ingredients of Seq. A in a suitable blender. When the mixture is uniform, grind or pulverize through a 0.010′′ Herringbone screen. Check the uniformity and fineness of the grind by pressing a sample between two pieces of white filter paper. If the batch is uniform and free of pigment specks, return the batch to the blender and continue mixing. Premix Seq. B materials in a separate container and disperse until the phase is completely uniform. Grind or pulverize Seq. B through a 0.010′′ Herringbone screen. Add the Seq. B mix to the Seq. A batch and mix until the batch is completely uniform and homogeneous. Premix Seq. C in a separate vessel. Spray Seq.

Abstract

The present invention provides a cosmetic mineral foundation, which is a pressed powder, comprising unfermented green rooibos extract (aspalathus linearis leaf), which functions as an antioxidant, and helps reduce the appearance of fine lines and wrinkles, and diminish signs of aging caused by free-radical damage. The foundation is gentle for all skin types, can be used daily, and provides effective anti-aging treatment as well as quality skin coverage.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This Continuation-in-Part Patent Application claims the benefit of earlier filed U.S. patent application Ser. No. 11/655,420, filed on Jan. 19, 2007 whose entire contents are hereby incorporated by reference.
    • BACKGROUND
  • 1. Field of the Invention
  • The present invention relates to cosmetic compositions and, in particular, to a cosmetic foundation.
  • 2. Description of the Related Art
  • There is always a need in the cosmetic industry for improved products which function effectively, and improve the overall quality of the skin. Powder foundations which may come in a pressed or loose powder form, are well known cosmetics, and have been used for many years. Most powder and pressed powder foundations provide skin coverage and color enhancement for affecting the temporary look of the skin, and sun protection. Additionally, there is a constant need for improved cosmetics which provide various skin benefits and enhance the overall quality of the skin. Users of cosmetics such as foundations typically use other skin benefiting products, which they may apply either underneath the foundation, or at a time when the foundation is not worn, so as to not affect the functionality of the foundation. Hence, a foundation which improves the overall skin quality, while providing skin coverage, is highly desirable.
    • SUMMARY
  • The present invention provides a cosmetic mineral foundation, which is a pressed powder, comprising unfermented green rooibos extract (aspalathus linearis leaf) combined with stoechas lavender extract, ascorbyl palmitate, tocopheryl acetate, aloe barbadensis leaf juice and zinc oxide, which is preferably micronized. Other ingredients may include boron nitride, zinc stearate, lauroyl lysine, octyldodecyl stearoyl stearate, caprylic/capric triglyceride, mica, bisabolol, and coloring agents preferably comprising titanium dioxide and iron oxide. The foundation is gentle for all skin types, can be used daily, and provides significant skin benefits including antioxidant, anti-irritant, anti-microbial, anti-allergenic, and anti-aging benefits. It further helps reduce the appearance of fine lines and wrinkles, and diminish signs of aging caused by free-radical damage, as well as quality skin coverage. As such, it provides not just color enhancement, but also benefits the skin.
    • DETAILED DESCRIPTION
  • The detailed description set forth below is intended as a description of exemplary embodiments and is not intended to represent the only forms in which the exemplary embodiments may be constructed and/or utilized. The description sets forth the functions and the sequence of steps for constructing and/or operating the exemplary embodiments. However, it is to be understood that the same or equivalent functions and sequences may be accomplished by different exemplary methods are also intended to be encompassed within the spirit and scope of the invention.
  • As used herein, “safe and effective amount” means a sufficient amount of a compound, composition or other material described by this phrase to significantly induce a positive modification in the condition being treated, but low enough to avoid undue side effects (e.g., significant skin irritation or sensitization), within the scope of sound judgment of the skilled person. The safe and effective amount of the compound, composition or other material may vary with the particular skin being treated, the age and physical condition of the biological subject being treated, the severity of the condition, the duration of treatment, the nature of concurrent therapy, the specific compound, composition, or other material employed, the particular cosmetically acceptable topical carrier utilized, and the factors within the knowledge and expertise of the skilled person.
  • The present invention provides a cosmetic foundation, which is a pressed mineral powder, comprising unfermented green rooibos extract (aspalathus linearis leaf) combined with stoechas lavender extract, ascorbyl palmitate, tocopheryl acetate, aloe barbadensis leaf juice, bisabolol, and zinc oxide, which is preferably micronized. Other ingredients may include boron nitride, zinc stearate, lauroyl lysine, octyldodecyl stearoyl stearate, caprylic/capric triglyceride, mica, and coloring agents preferably comprising titanium dioxide and iron oxide. The foundation is gentle for all skin types, can be used daily, and provides significant skin benefits including antioxidant, anti-irritant, anti-microbial, anti-allergenic, and anti-aging benefits. It further helps reduce the appearance of fine lines and wrinkles, and diminish signs of aging caused by free-radical damage, as well as quality skin coverage.
  • Green rooibos extract is a natural botanical having anti-oxidant, anti-inflammatory/anti-irritant, and free radical scavenging properties, partly due to its unique flavonoid content which includes aspalathin. Additionally, it has high anti-allergenic and anti-microbial effects and further prevents eczema. Its properties are ascribed to the high level of antioxidants, minerals, and polyphenols. While its use in cosmetics is generally known, it is much more commonly used and known as an anti-oxidant tea, where it is typically used in its fermented form. The fermentation process normally starts naturally immediately after the plant is harvested. However, fermentation alters and reduces the flavonoid composition hence significantly reducing the anti-oxidant activity. The antioxidant activity of the unfermented powdered extract has been found to be much higher than the usual rooibos extract which is fermented. The mineral powder foundation of the present invention includes a safe and effective amount of unfermented green rooibos extract (aspalathus linearis leaf), preferably at a concentration of approximately around up to 1% by weight, and more preferably at about 0.1% by weight.
  • Stoechas lavender extract works as an anti-aging agent. It is preferably formulated with caprylic/capric triglyceride under the trade name Lavandox™, which is commercially available from Barnet Products®. The foundation of the present invention includes a safe and effective amount of Lavandox™, preferably at a concentration of approximately 0.1-3%, and more preferably at about 1.0%.
  • The formulation further includes a safe and effective amount of vitamins comprising ascorbyl palmitate and tocopheryl acetate, which are anti-oxidant. The formulation preferably includes ascrobyl palmitate and tocopheryl acetate, each at a concentration of approximately 0.001-2% by weight, and more preferably at around 0.05%.
  • The formulation further includes aloe barbadensis leaf juice, which provides skin healing/soothing benefits, at a concentration of approximately 0.001 to 2%, and more preferably at around 0.02%.
  • The formulation further includes bisabolol, which acts as a skin soothing agent, at a concentration of approximately 0.01-1% by weight, and more preferably at around 0.1%.
  • The zinc oxide used in the present formulation is preferably micronized, having a particle size of preferably less than 0.2 microns, and more preferably, about less than 0.1 microns, which increase its sunscreening effectiveness and esthetics compared to larger particles. The formulation of the present invention preferably uses zinc oxide at a concentration of roughly about 9-15% by weight, and more preferably at about 12%.
  • The formulation of the present invention may further include other ingredients such as slip agents, skin adhesion agents, binders, emollients, etc. The preferred carrier ingredients of the present invention include boron nitride, at a concentration of approximately 2-15% by weight, and more preferably at around 5%, zinc stearate, at a concentration of approximately 2-15% by weight, and more preferably at around 5%, lauroyl lysine, at a concentration of approximately 0.2-1.5% by weight, and more preferably at around 0.5%, and octyldodecyl stearoyl stearate, at a concentration of approximately 2-15% by weight, and more preferably at around 5%.
  • The formulation further contains visual effect agents comprising mica, and colorants, which are preferably mineral colorants such as titanium dioxide and iron oxides. The concentrations of the visual effect agents will depend on the color shades and visual effects desired, and the particular agents used. For the particular visual affect agents in Examples 1-9 below, which include mica, titanium dioxide, and iron oxide, the combined concentrations may vary, between roughly about 40-85% by weight of total composition, and is preferably between 70-74%. Although it is more beneficial to use mineral colorants, one skilled in the art may be able to use artificial colors to create a similar formulation. Additionally, the colorants described herein may vary depending on the manufacturer and desired color effect.
  • The foundation of the present invention is preferably made of natural botanicals and minerals, and preferably contains no preservatives, fragrances, dyes or chemicals, and oils, and is preferably formulated without fillers such as silicone, talc, and mineral oil. It is especially formulated for troubled and sensitive skin. The inert minerals do not support bacterial growth. The natural pigments do not pile on the edges of skin pores, which would make pores more visible. Additionally, the formulation is designed to deflect light away from skin imperfections, for a line minimizing effect.
    • EXAMPLE 1
  • The following is an example for the preparation of a mineral foundation having a “Chocolate” colored shade:
  • SEQ. TRADE NAME INCI Name % Wt Supplier
    (A) Z-Cote ® Zinc Oxide 12.000 BASF
    (A) Titanium Dioxide Titanium 0.001 MPSI
    USP Dioxide
    (CI77891)
    (A) Unipure Red Iron Oxide 4.500 LCW
    (LC381, Lot (CI77491)
    B7259
    (A) Unipure Yellow Iron Oxide 3.600 LCW
    (LC181, Lot (CI77492)
    B1948)
    (A) Unipure Black Iron Oxide 2.000 LCW
    (LC989, Lot (CI77499)
    B1273)
    (A) Boron Nitride Boron Nitride 5.000 GE Adv Ceramics
    Powder (CC6058)
    (A) Zinc Stearate Zinc Sterate 5.000 Ferro Corp.
    USP
    (A) Macare L2 Lauroyl Lysine 0.500 Mason Chemical
    (A) Sericite R0114 Mica 59.079 LCW
    (B) Sericite R0114 Mica 2.000 LCW
    (B) Ascorbyl Ascorbyl 0.050 DSM Nutritionals
    Palmitate-NF Palmitate
    FCC
    (B) Vitamin E Tocopheryl 0.050 BASF
    Acetate Acetate
    (B) Alpha-Bisabolol Bisabolol 0.100 BASF
    Natural
    (B) Unfermented Aspalathus 0.100 Jarchem
    Green Rooibus Linearis Leaf
    Extract Extract
    (B) Aloe Vera Spray Aloe 0.200 Concentrated Aloe
    Dried Powder - Barbadensis
    SC Leaf Juice
    (C) Ceraphyl 847 Octylodecyl 5.000 ISP Corporation
    Stearoyl Sterate
    (C) Lavandox Caprylic/Capric 1.000 Barnet Products
    Triglyceride
    (and)
    Lavandula
    Stoechas
    Extract
    • EXAMPLE 2
  • The following is an example for the preparation of a mineral foundation having a “Bisque” colored shade:
  • SEQ. TRADE NAME INCI Name % Wt Supplier
    (A) Z-Cote ® (Zinc Zinc Oxide 12.00 BASF
    Oxide USP
    (A) Titanium Dioxide Titanium 14.00 MPSI
    USP Dioxide
    (CI77891)
    (A) Unipure Red Iron Oxide 0.40 LCW
    (LC381, Lot (CI77491)
    B7259)
    (A) Unipure Yellow Iron Oxide 2.00 LCW
    (LC181, Lot (C77492)
    B1948)
    (A) Unipure Black Iron Oxide 0.20 LCW
    (LC989, Lot (CI77499)
    B1273)
    (A) Boron Nitride Boron Nitride 5.00 GE Adv Ceramics
    Powder (CC6058)
    (A) Zinc Stearate Zinc Stearate 5.00 Ferro Corp.
    USP
    (A) Macre L2 Lauroyl Lysine 0.50 Mason Chemical
    (A) Sericite R0114 Mica 52.58 LCW
    (B) Sericite Ro114 Mica 2.00 LCW
    (B) Ascorbyl Ascorbyl 0.05 DSM Nutritionals
    Palmitate-NF Palmitate
    FCC
    (B) Vitamin E Tocopheryl 0.05 BASF
    Acetate Acetate
    (B) Alpha-Bisabolol Bisabolol 0.10 BASF
    Natural
    (B) Unfermented Aspalathus 0.10 Jarchem
    Green Rooibos Linearis Leaf
    Extract Extract
    (B) Aloe Vera Spray Aloe 0.02 Concentrated Aloe
    Dried Powder-SC Barbadensis
    Leaf Juice
    (C) Ceraphyl 847 Octylodecyl 5.00 Binder/Emollient
    Stearoyl Sterate
    (C) Lavandox Caprylic/Capric 1.00 Barnet Products
    Triglyceride
    (and)
    Lavandula
    Stoechas
    Extract
    • EXAMPLE 3
  • The following is an example for the preparation of a mineral foundation having a “Buff” colored shade:
  • SEQ. TRADE NAME INCI Name % Wt Supplier
    (A) Z-Cote ® (Zinc Zinc Oxide 12.00 BASF
    Oxide USP
    (A) Titanium Dioxide Titanium 14.00 MPSI
    USP Dioxide
    (CI77891)
    (A) Unipure Red Iron Oxide 0.40 LCW
    (LC381, Lot (CI77491)
    B7259)
    (A) Unipure Yellow Iron Oxide 3.00 LCW
    (LC181, Lot (C77492)
    B1948)
    (A) Unipure Black Iron Oxide 0.10 LCW
    (LC989, Lot (CI77499)
    B1273)
    (A) Boron Nitride Boron Nitride 5.00 GE Adv Ceramics
    Powder (CC6058)
    (A) Zinc Stearate Zinc Stearate 5.00 Ferro Corp.
    USP
    (A) Macre L2 Lauroyl Lysine 0.50 Mason Chemical
    (A) Sericite R0114 Mica 51.68 LCW
    (B) Sericite Ro114 Mica 2.00 LCW
    (B) Ascorbyl Ascorbyl 0.05 DSM Nutritionals
    Palmitate-NF Palmitate
    FCC
    (B) Vitamin E Tocopheryl 0.05 BASF
    Acetate Acetate
    (B) Alpha-Bisabolol Bisabolol 0.10 BASF
    Natural
    (B) Unfermented Aspalathus 0.10 Jarchem
    Green Rooibos Linearis Leaf
    Extract Extract
    (B) Aloe Vera Spray Aloe 0.02 Concentrated Aloe
    Dried Powder-SC Barbadensis
    Leaf Juice
    (C) Ceraphyl 847 Octylodecyl 5.00 Binder/Emollient
    Stearoyl Sterate
    (C) Lavandox Caprylic/Capric 1.00 Barnet Products
    Triglyceride
    (and)
    Lavandula
    Stoechas
    Extract
    • EXAMPLE 4
  • The following is an example for the preparation of a mineral foundation having a “Latte” colored shade:
  • SEQ. TRADE NAME INCI Name % Wt Supplier
    (A) Z-Cote ® (Zinc Zinc Oxide 12.00 BASF
    Oxide USP
    (A) Titanium Dioxide Titanium 20.00 MPSI
    USP Dioxide
    (CI77891)
    (A) Unipure Red Iron Oxide 0.50 LCW
    (LC381, Lot (CI77491)
    B7259)
    (A) Unipure Yellow Iron Oxide 2.40 LCW
    (LC181, Lot (C77492)
    B1948)
    (A) Unipure Black Iron Oxide 0.26 LCW
    (LC989, Lot (CI77499)
    B1273)
    (A) Boron Nitride Boron Nitride 5.00 GE Adv Ceramics
    Powder (CC6058)
    (A) Zinc Stearate Zinc Stearate 5.00 Ferro Corp.
    USP
    (A) Macre L2 Lauroyl Lysine 0.50 Mason Chemical
    (A) Sericite R0114 Mica 46.02 LCW
    (B) Sericite Ro114 Mica 2.00 LCW
    (B) Ascorbyl Ascorbyl 0.05 DSM Nutritionals
    Palmitate-NF Palmitate
    FCC
    (B) Vitamin E Tocopheryl 0.05 BASF
    Acetate Acetate
    (B) Alpha-Bisabolol Bisabolol 0.10 BASF
    Natural
    (B) Unfermented Aspalathus 0.10 Jarchem
    Green Rooibos Linearis Leaf
    Extract Extract
    (B) Aloe Vera Spray Aloe 0.02 Concentrated Aloe
    Dried Powder-SC Barbadensis
    Leaf Juice
    (C) Ceraphyl 847 Octylodecyl 5.00 Binder/Emollient
    Stearoyl Sterate
    (C) Lavandox Caprylic/Capric 1.00 Barnet Products
    Triglyceride
    (and)
    Lavandula
    Stoechas
    Extract
    • EXAMPLE 5
  • The following is an example for the preparation of a mineral foundation having a “Nude” colored shade:
  • SEQ. TRADE NAME INCI Name % Wt Supplier
    (A) Z-Cote ® (Zinc Zinc Oxide 12.00 BASF
    Oxide USP
    (A) Titanium Dioxide Titanium 15.00 MPSI
    USP Dioxide
    (CI77891)
    (A) Unipure Red Iron Oxide 0.75 LCW
    (LC381, Lot (CI77491)
    B7259)
    (A) Unipure Yellow Iron Oxide 1.80 LCW
    (LC181, Lot (C77492)
    B1948)
    (A) Unipure Black Iron Oxide 0.21 LCW
    (LC989, Lot (CI77499)
    B1273)
    (A) Boron Nitride Boron Nitride 5.00 GE Adv Ceramics
    Powder (CC6058)
    (A) Zinc Stearate Zinc Stearate 5.00 Ferro Corp.
    USP
    (A) Macre L2 Lauroyl Lysine 0.50 Mason Chemical
    (A) Sericite R0114 Mica 51.42 LCW
    (B) Sericite Ro114 Mica 2.00 LCW
    (B) Ascorbyl Ascorbyl 0.05 DSM Nutritionals
    Palmitate-NF Palmitate
    FCC
    (B) Vitamin E Tocopheryl 0.05 BASF
    Acetate Acetate
    (B) Alpha-Bisabolol Bisabolol 0.10 BASF
    Natural
    (B) Unfermented Aspalathus 0.10 Jarchem
    Green Rooibos Linearis Leaf
    Extract Extract
    (B) Aloe Vera Spray Aloe 0.02 Concentrated Aloe
    Dried Powder-SC Barbadensis
    Leaf Juice
    (C) Ceraphyl 847 Octylodecyl 5.00 Binder/Emollient
    Stearoyl Sterate
    (C) Lavandox Caprylic/Capric 1.00 Barnet Products
    Triglyceride
    (and)
    Lavandula
    Stoechas
    Extract
    • EXAMPLE 6
  • The following is an example for the preparation of a mineral foundation having a “Golden” colored shade:
  • SEQ. TRADE NAME INCI Name % Wt Supplier
    (A) Z-Cote ® (Zinc Zinc Oxide 12.00 BASF
    Oxide USP
    (A) Titanium Dioxide Titanium 11.00 MPSI
    USP Dioxide
    (CI77891)
    (A) Unipure Red Iron Oxide 0.38 LCW
    (LC381, Lot (CI77491)
    B7259)
    (A) Unipure Yellow Iron Oxide 3.00 LCW
    (LC181, Lot (C77492)
    B1948)
    (A) Unipure Black Iron Oxide 0.22 LCW
    (LC989, Lot (CI77499)
    B1273)
    (A) Boron Nitride Boron Nitride 5.00 GE Adv Ceramics
    Powder (CC6058)
    (A) Zinc Stearate Zinc Stearate 5.00 Ferro Corp.
    USP
    (A) Macre L2 Lauroyl Lysine 0.50 Mason Chemical
    (B) Sericite R0114 Mica 54.58 LCW
    (B) Sericite Ro114 Mica 2.00 LCW
    (B) Ascorbyl Ascorbyl 0.05 DSM Nutritionals
    Palmitate-NF Palmitate
    FCC
    (B) Vitamin E Tocopheryl 0.05 BASF
    Acetate Acetate
    (B) Alpha-Bisabolol Bisabolol 0.10 BASF
    Natural
    (B) Unfermented Aspalathus 0.10 Jarchem
    Green Rooibos Linearis Leaf
    Extract Extract
    (B) Aloe Vera Spray Aloe 0.02 Concentrated Aloe
    Dried Powder-SC Barbadensis
    Leaf Juice
    (C) Ceraphyl 847 Octylodecyl 5.00 Binder/Emollient
    Stearoyl Sterate
    (C) Lavandox Caprylic/Capric 1.00 Barnet Products
    Triglyceride
    (and)
    Lavandula
    Stoechas
    Extract
    • EXAMPLE 7
  • The following is an example for the preparation of a mineral foundation having a “Frost” colored shade:
  • SEQ. TRADE NAME INCI Name % Wt Supplier
    (A) Z-Cote ® (Zinc Zinc Oxide 12.00 BASF
    Oxide USP
    (A) Titanium Dioxide Titanium 14.00 MPSI
    USP Dioxide
    (CI77891)
    (A) Unipure Red Iron Oxide 0.40 LCW
    (LC381, Lot (CI77491)
    B7259)
    (A) Unipure Yellow Iron Oxide 1.35 LCW
    (LC181, Lot (C77492)
    B1948)
    (A) Unipure Black Iron Oxide 0.06 LCW
    (LC989, Lot (CI77499)
    B1273)
    (A) Boron Nitride Boron Nitride 5.00 GE Adv Ceramics
    Powder (CC6058)
    (A) Zinc Stearate Zinc Stearate 5.00 Ferro Corp.
    USP
    (A) Macre L2 Lauroyl Lysine 0.50 Mason Chemical
    (A) Sericite R0114 Mica 53.37 LCW
    (B) Sericite Ro114 Mica 2.00 LCW
    (B) Ascorbyl Ascorbyl 0.05 DSM Nutritionals
    Palmitate-NF Palmitate
    FCC
    (B) Vitamin E Tocopheryl 0.05 BASF
    Acetate Acetate
    (B) Alpha-Bisabolol Bisabolol 0.10 BASF
    Natural
    (B) Unfermented Aspalathus 0.10 Jarchem
    Green Rooibos Linearis Leaf
    Extract Extract
    (B) Aloe Vera Spray Aloe 0.02 Concentrated Aloe
    Dried Powder-SC Barbadensis
    Leaf Juice
    (C) Ceraphyl 847 Octylodecyl 5.00 Binder/Emollient
    Stearoyl Sterate
    (C) Lavandox Caprylic/Capric 1.00 Barnet Products
    Triglyceride
    (and)
    Lavandula
    Stoechas
    Extract
    • EXAMPLE 8
  • The following is an example for the preparation of a mineral foundation having a “Almond” colored shade:
  • SEQ. TRADE NAME INCI Name % Wt Supplier
    (A) Z-Cote ® (Zinc Zinc Oxide 12.00 BASF
    Oxide USP
    (A) Titanium Dioxide Titanium 10.50 MPSI
    USP Dioxide
    (CI77891)
    (A) Unipure Red Iron Oxide 1.05 LCW
    (LC381, Lot (CI77491)
    B7259)
    (A) Unipure Yellow Iron Oxide 4.75 LCW
    (LC181, Lot (C77492)
    B1948)
    (A) Unipure Black Iron Oxide 0.92 LCW
    (LC989, Lot (CI77499)
    B1273)
    (A) Boron Nitride Boron Nitride 5.00 GE Adv Ceramics
    Powder (CC6058)
    (A) Zinc Stearate Zinc Stearate 5.00 Ferro Corp.
    USP
    (A) Macre L2 Lauroyl Lysine 0.50 Mason Chemical
    (A) Sericite R0114 Mica 51.96 LCW
    (B) Sericite Ro114 Mica 2.00 LCW
    (B) Ascorbyl Ascorbyl 0.05 DSM Nutritionals
    Palmitate-NF Palmitate
    FCC
    (B) Vitamin E Tocopheryl 0.05 BASF
    Acetate Acetate
    (B) Alpha-Bisabolol Bisabolol 0.10 BASF
    Natural
    (B) Unfermented Aspalathus 0.10 Jarchem
    Green Rooibos Linearis Leaf
    Extract Extract
    (B) Aloe Vera Spray Aloe 0.02 Concentrated Aloe
    Dried Powder-SC Barbadensis
    Leaf Juice
    (C) Ceraphyl 847 Octylodecyl 5.00 Binder/Emollient
    Stearoyl Sterate
    (C) Lavandox Caprylic/Capric 1.00 Barnet Products
    Triglyceride
    (and)
    Lavandula
    Stoechas
    Extract
  • In each of Examples 1-9, blend all ingredients of Seq. A in a suitable blender. When the mixture is uniform, grind or pulverize through a 0.010″ Herringbone screen. Check the uniformity and fineness of the grind by pressing a sample between two pieces of white filter paper. If the batch is uniform and free of pigment specks, return the batch to the blender and continue mixing. Premix Seq. B materials in a separate container and disperse until the phase is completely uniform. Grind or pulverize Seq. B through a 0.010″ Herringbone screen. Add the Seq. B mix to the Seq. A batch and mix until the batch is completely uniform and homogeneous. Premix Seq. C in a separate vessel. Spray Seq. C into the combined Sequences A and B batch. Mix until the binder has completely wet out the powder. When the phases are completely uniform, grind or pulverize through a 0.010″ Herringbone screen. Return the batch to the blender and shade adjust the batch to a standard. When the batch matches the standard, Jet Mill the batch and place directly into airtight containers and store until ready for filling.
  • In closing, it is to be understood that the exemplary embodiments described herein are illustrative of the principles of the present invention. Other modifications that may be employed are within the scope of the invention. Thus, by way of example, but not of limitation, alternative configurations may be utilized in accordance with the teachings herein. Accordingly, the description is illustrative and not meant to be a limitation thereof.

Claims (17)

1. A cosmetic foundation comprising:
approximately 0.1% by weight of total composition of unfermented green rooibos extract;
approximately 1% by weight of total composition of stoechas lavender extract,
approximately 0.05% by weight of total composition of ascorbyl palmitate
approximately 0.05% by weight of total composition of tocopheryl acetate
approximately 0.02% by weight of total composition of aloe barbadensis leaf juice,
approximately 0.1% by weight of total composition of bisabool
approximately 12% by weight of total composition of micronized zinc oxide; and
approximately up to 85% by weight of total composition of visual effect and coloring agents comprising a combination of titanium dioxide, iron oxides, and micas.
2. A cosmetic foundation comprising:
unfermented green rooibos extract;
stoechas lavender extract;
vitamins and skin soothing agents comprising ascorbyl palmitate, tocopheryl acetate, aloe barbadensis leaf juice, bisabolol or combinations thereof;
micronized zinc oxide;
a carrier comprising boron nitride, zinc stearate, lauroyl lysine, octyldodecyl stearoyl stearate, caprylic/capric triglyceride, or combination thereof; and
visual effect and coloring agents comprising mica, titanium dioxide, iron oxide, or combination thereof, wherein
said foundation is a pressed mineral powder.
3. The foundation of claim 2, said foundation comprising: approximately up to 1% by weight of unfermented green rooibos extract;
approximately 0.1-3% by weight of stoechas lavender extract;
approximately 0.001-2% by weight of ascorbyl palmitate;
approximately 0.001-2% by weight of tocopheryl acetate;
approximately 0.001 to 2% by weight of aloe barbadensis leaf juice;
approximately 0.01-1% by weight of bisabolol;
approximately 9-15% by weight of micronized zinc oxide;
approximately 2-15% by weight of boron nitride;
approximately 2-15% by weight of zinc stearate;
approximately 0.2-1.5% by weight of Lauroyl Lysine;
approximately 2-15% by weight of octyldodecyl stearoyl stearate; and
approximately 40-85% by weight of said coloring agents, wherein
said foundation is effective in protecting the skin against free radical damage and further acts as an anti-inflammatory agent.
4. The composition of claim 2 wherein said foundation is free of preservatives and artificial fragrances and colors.
5. The composition of claim 2 wherein said foundation provides antioxidant, anti-irritant, anti-microbial, anti-allergenic, and anti-aging benefits, and further helps reduce the appearance of fine lines and wrinkles, and diminish signs of aging caused by free-radical damage.
6. The cosmetic foundation of claim 2, wherein said foundation is made of natural botanicals and minerals.
7. A method of providing skin coverage, while, at the same time, providing skin treatment against signs of aging, comprising applying a foundation to the skin, said foundation comprising:
green rooibos extract,
stoechas lavender extract;
vitamins and skin soothing agents comprising ascorbyl palmitate, tocopheryl acetate, aloe barbadensis leaf juice, bisabolol or combinations thereof;
zinc oxide;
a carrier comprising boron nitride, zinc stearate, lauroyl lysine, octyldodecyl stearoyl stearate, caprylic/capric triglyceride, or combinations thereof; and
visual effect and coloring agents comprising mica, titanium dioxide, iron oxide, or combination thereof, wherein
said rooibus extract is effective in protecting the skin against free radical damage and further acts as an anti-inflammatory agent.
8. The method of claim 7 wherein said foundation is a pressed powder.
9. The method of claim 7 wherein said foundation has anti-irritant, anti-microbial, and anti-allergenic skin benefiting properties.
10. The method of claim 7 wherein said green rooibos extract is unfermented.
11. The method of claim 7 wherein the zinc oxide is micronized.
12. The method of claim 7, said foundation comprising approximately up to 1% by weight of unfermented green rooibos extract.
13. The method of claim 12, said foundation further comprising:
approximately 0.1-3% by weight of stoechas lavender extract;
approximately 0.001-2% by weight of ascorbyl palmitate;
approximately 0.001-2% by weight of tocopheryl acetate;
approximately 0.001 to 2% by weight of aloe barbadensis leaf juice; and
approximately 0.01-1% by weight of bisabolol.
14. The method of claim 12, said foundation further comprising approximately 9-15% by weight of micronized zinc oxide.
15. The method of claim 12, said foundation further comprising:
approximately 2-15% by weight of boron nitride;
approximately 2-15% by weight of zinc stearate;
approximately 0.2-1.5% by weight of Lauroyl Lysine; and
approximately 2-15% by weight of octyldodecyl stearoyl stearate.
16. The method of claim 12, said foundation comprising approximately 40-85% by weight of said visual effect and coloring agents.
17. The method of claim 7 wherein said foundation comprises:
approximately 0.1% by weight of total composition of unfermented green rooibos extract;
approximately 1% by weight of total composition of stoechas lavender extract,
approximately 0.05% by weight of total composition of ascorbyl palmitate
approximately 0.05% by weight of total composition of tocopheryl acetate
approximately 0.02% by weight of total composition of aloe barbadensis leaf juice,
approximately 0.1% by weight of total composition of bisabool
approximately 12% by weight of total composition of micronized zinc oxide; and
approximately up to 85% by weight of total composition of visual effect and coloring agents comprising a combination of titanium dioxide, iron oxides, and micas.
US11/899,773 2007-01-19 2007-09-07 Cosmetic foundation Abandoned US20080175931A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US11/899,773 US20080175931A1 (en) 2007-01-19 2007-09-07 Cosmetic foundation
PCT/US2008/002148 WO2009032022A1 (en) 2007-09-07 2008-02-19 Cosmetic foundation
US12/701,394 US8252298B2 (en) 2007-09-07 2010-02-05 Color cosmetic
US13/597,154 US20120321684A1 (en) 2007-09-07 2012-08-28 Color Cosmetic

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/655,420 US20080175805A1 (en) 2007-01-19 2007-01-19 Cosmetic foundation
US11/899,773 US20080175931A1 (en) 2007-01-19 2007-09-07 Cosmetic foundation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/655,420 Continuation-In-Part US20080175805A1 (en) 2007-01-19 2007-01-19 Cosmetic foundation

Publications (1)

Publication Number Publication Date
US20080175931A1 true US20080175931A1 (en) 2008-07-24

Family

ID=40429161

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/899,773 Abandoned US20080175931A1 (en) 2007-01-19 2007-09-07 Cosmetic foundation
US12/701,394 Active 2031-04-28 US8252298B2 (en) 2007-09-07 2010-02-05 Color cosmetic
US13/597,154 Abandoned US20120321684A1 (en) 2007-09-07 2012-08-28 Color Cosmetic

Family Applications After (2)

Application Number Title Priority Date Filing Date
US12/701,394 Active 2031-04-28 US8252298B2 (en) 2007-09-07 2010-02-05 Color cosmetic
US13/597,154 Abandoned US20120321684A1 (en) 2007-09-07 2012-08-28 Color Cosmetic

Country Status (2)

Country Link
US (3) US20080175931A1 (en)
WO (1) WO2009032022A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000564A2 (en) * 2008-06-09 2010-01-07 Nestec S.A. Rooibos and inflammation
US20100119463A1 (en) * 2008-11-12 2010-05-13 June Jacobs Antioxidant compositions for the cleansing and conditioning of skin
US20110213170A1 (en) * 2010-02-26 2011-09-01 Daniele Vinci Estolide derivatives useful as biolubricants
US8558022B2 (en) 2010-04-29 2013-10-15 Dow Global Technologies Llc Oligomerized ester alkoxylate compositions
US8580984B2 (en) 2009-07-10 2013-11-12 Dow Global Technologies Llc Esters of secondary hydroxy fatty acid oligomers and preparation thereof
US10159637B2 (en) 2016-06-10 2018-12-25 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010020507A1 (en) * 2010-05-14 2011-11-17 Eckart Gmbh Metal cations and phosphorus and / or sulfur-containing anions having metallic effect pigments, processes for the preparation of these metallic effect pigments and use
EP2935285B1 (en) * 2012-12-19 2017-02-22 Colgate-Palmolive Company Zinc-lysine complex
US9168393B2 (en) 2013-03-13 2015-10-27 Johnson & Johnson Consumer Inc. Pigmented skin-care compositions
US9168209B2 (en) 2013-03-13 2015-10-27 Johnson & Johnson Consumer Inc. Pigmented skin-care compositions
US9320687B2 (en) 2013-03-13 2016-04-26 Johnson & Johnson Consumer Inc. Pigmented skin-care compositions
US9168394B2 (en) 2013-03-13 2015-10-27 Johnson & Johnson Consumer Inc. Pigmented skin-care compositions
WO2017003234A1 (en) * 2015-06-30 2017-01-05 주식회사 아모레퍼시픽 Makeup cosmetic composition containing multiple composite powder
US20170189289A1 (en) * 2015-12-30 2017-07-06 Natura Cosméticos S.A. Cosmetic compositions comprising a synergistic combination of sweat absorbing particles and adsorbing particles and use thereof
US11033471B2 (en) 2017-12-20 2021-06-15 L'oreal Pigment compositions
WO2023056278A1 (en) * 2021-09-29 2023-04-06 Love Sun Body Ip Holdings Llc Facial and body sunscreen compositions

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073364A (en) * 1990-06-19 1991-12-17 Revlon, Inc. Pressed powder cosmetic product
US6294186B1 (en) * 1997-06-04 2001-09-25 Peter William Beerse Antimicrobial compositions comprising a benzoic acid analog and a metal salt
US6461626B1 (en) * 1999-08-18 2002-10-08 The Procter & Gamble Company Wear resistant topical compositions having improved feel
US6495123B1 (en) * 2001-09-12 2002-12-17 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic composition with organic sunscreen and porous powder particles
US20040191190A1 (en) * 2001-08-02 2004-09-30 Gilles Pauly Cosmetic and/or pharmaceutical preparations containing plant extracts
US20050100520A1 (en) * 2003-09-30 2005-05-12 Kao Corporation Deodorant composition
US20050118283A1 (en) * 2002-04-09 2005-06-02 Calverley Ruth R. Skincare compositions and methods
US20060019855A1 (en) * 2004-06-21 2006-01-26 P & Pf Co., Ltd. Composition for a bactericidal, disinfecting, and cleansing foam agent
US20060018867A1 (en) * 2004-05-12 2006-01-26 Ichimaru Pharcos Co., Ltd Cosmetic composition and production thereof
US20060031361A1 (en) * 2004-07-01 2006-02-09 International Business Machines Corporation Method and apparatus for conversational annotation for instant messaging systems
US20060079414A1 (en) * 2001-12-18 2006-04-13 Claus Nieendick Highly concentrated, free-flowing pearly lustre concentrates

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623396A (en) * 1983-09-14 1986-11-18 Shiseido Company Ltd. Titanium-mica composite material
US5116664A (en) * 1988-02-09 1992-05-26 Shiseido Company Ltd. Titanium-mica composite material
US5340569A (en) * 1992-09-10 1994-08-23 Elizabeth Arden Co., Division Of Conopco, Inc. Color cosmetic composition
EP0701810B1 (en) * 1994-09-14 2004-11-17 Shiseido Company Limited Skin-colour adjusting method, and coloured titanium oxide coated mica used therefor
TW513308B (en) * 1998-11-02 2002-12-11 Shiseido Co Ltd Light responsive high colour rendering cosmetics for make-up containing photochromic mica-titanium and photochromic titanium oxide with changing brightness by light
US7098189B2 (en) * 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
US20080112909A1 (en) * 2003-06-24 2008-05-15 Ppg Industries Ohio, Inc. Compositions for providing color to animate objects and related methods
US7025966B2 (en) * 2003-12-05 2006-04-11 Mary Kay Inc. Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
EP1731134B1 (en) * 2004-03-17 2015-10-07 Hayashibara Co., Ltd. Functional powders
US7427417B2 (en) * 2004-03-19 2008-09-23 Sequim Lavender Company, Llc Aromatherapy delivery system
US8349067B2 (en) * 2006-11-09 2013-01-08 Sun Chemical Corp. Multi-colored lustrous pearlescent pigments
US8906154B2 (en) * 2006-11-09 2014-12-09 Sun Chemical Corporation Coating, ink, or article comprising multi-colored lustrous pearlescent pigments
US8211224B2 (en) * 2006-11-09 2012-07-03 Sun Chemical Corp. Multi-colored lustrous pearlescent pigments and process for making
US8221536B2 (en) * 2006-11-09 2012-07-17 Sun Chemical Corp. Cosmetic comprising multi-colored lustrous pearlescent pigments

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073364A (en) * 1990-06-19 1991-12-17 Revlon, Inc. Pressed powder cosmetic product
US6294186B1 (en) * 1997-06-04 2001-09-25 Peter William Beerse Antimicrobial compositions comprising a benzoic acid analog and a metal salt
US6461626B1 (en) * 1999-08-18 2002-10-08 The Procter & Gamble Company Wear resistant topical compositions having improved feel
US20040191190A1 (en) * 2001-08-02 2004-09-30 Gilles Pauly Cosmetic and/or pharmaceutical preparations containing plant extracts
US6495123B1 (en) * 2001-09-12 2002-12-17 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic composition with organic sunscreen and porous powder particles
US20060079414A1 (en) * 2001-12-18 2006-04-13 Claus Nieendick Highly concentrated, free-flowing pearly lustre concentrates
US20050118283A1 (en) * 2002-04-09 2005-06-02 Calverley Ruth R. Skincare compositions and methods
US20050100520A1 (en) * 2003-09-30 2005-05-12 Kao Corporation Deodorant composition
US20060018867A1 (en) * 2004-05-12 2006-01-26 Ichimaru Pharcos Co., Ltd Cosmetic composition and production thereof
US20060019855A1 (en) * 2004-06-21 2006-01-26 P & Pf Co., Ltd. Composition for a bactericidal, disinfecting, and cleansing foam agent
US20060031361A1 (en) * 2004-07-01 2006-02-09 International Business Machines Corporation Method and apparatus for conversational annotation for instant messaging systems

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000564A2 (en) * 2008-06-09 2010-01-07 Nestec S.A. Rooibos and inflammation
WO2010000564A3 (en) * 2008-06-09 2010-02-25 Nestec S.A. Rooibos and inflammation
US20100119463A1 (en) * 2008-11-12 2010-05-13 June Jacobs Antioxidant compositions for the cleansing and conditioning of skin
WO2010056675A2 (en) * 2008-11-12 2010-05-20 June Jacobs Laboratories, Llc Antioxidant compositions for the cleansing and conditioning of skin
WO2010056675A3 (en) * 2008-11-12 2010-07-22 June Jacobs Laboratories, Llc Antioxidant compositions for the cleansing and conditioning of skin
US9126061B2 (en) 2008-11-12 2015-09-08 June Jacobs Laboratories, Llc Antioxidant compositions for the cleansing and conditioning of skin
US8580984B2 (en) 2009-07-10 2013-11-12 Dow Global Technologies Llc Esters of secondary hydroxy fatty acid oligomers and preparation thereof
US20110213170A1 (en) * 2010-02-26 2011-09-01 Daniele Vinci Estolide derivatives useful as biolubricants
US8558022B2 (en) 2010-04-29 2013-10-15 Dow Global Technologies Llc Oligomerized ester alkoxylate compositions
US10159637B2 (en) 2016-06-10 2018-12-25 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US10813872B2 (en) 2016-06-10 2020-10-27 Clarity Cosmetics Inc. Hair and scalp formulations
US11160746B2 (en) 2016-06-10 2021-11-02 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Also Published As

Publication number Publication date
US8252298B2 (en) 2012-08-28
WO2009032022A1 (en) 2009-03-12
US20120321684A1 (en) 2012-12-20
US20100209464A1 (en) 2010-08-19

Similar Documents

Publication Publication Date Title
US20080175931A1 (en) Cosmetic foundation
AU2009308057B2 (en) Powder makeup compositions and methods
EP1640042B1 (en) Cosmetic skin-whitening and cleansing composition comprising extracts from lotus, kiwi, orchids and liquorice
WO2002087529A1 (en) Hair dye compositions for dressing the hair
KR102062543B1 (en) Manufacturing method of emulsion containing titanium dioxide for blue light interception and cosmetic composition for protecting containing thereof
WO2024066643A1 (en) Sun-screening composition and use thereof
US20080175805A1 (en) Cosmetic foundation
CN110402134B (en) Cosmetic skin care composition
KR101466379B1 (en) Make-up Cosmetic Using Scoria Powder
KR20170018254A (en) Encapsulation method of nut pine oil and shampoo compositions using the same
US20090060960A1 (en) Preparation containing barium sulfate
US20200337986A1 (en) Dahlia pinnata composition, dahlia pinnata composition powder, cosmetic composition, and producing method therefor
KR101216410B1 (en) Composition of sun screening functional cosmetics for skin soothing effect using gynostem extract and resverol extract
MX2011009851A (en) A process for obtaining insoluble substances from genipap-extract precipitates, substances from genipap-extract precipitates and their uses.
KR101365256B1 (en) Make-up Cosmetic Using Scoria Powder
KR20100079278A (en) Composition for the anti-irritation effect on the scalp containing natural ingredients for hair colorants
KR20130075962A (en) Composition of sun screening functional cosmetics for skin soothing effect using gynostem extract
CN109199988B (en) Whitening skin care product and preparation method thereof
KR101995998B1 (en) Compositions for cushion cosmetics and manufacturing method thereof
WO2007007936A1 (en) Composition for hairdye comprising mulberry, mulberry leaves or mori radicis cortex
CN113520935B (en) Color multifunctional barrier cream and preparation method thereof
CN104173271A (en) Nostoc commune Vauch extract and preparation method and application thereof
KR102025398B1 (en) Liposome-coated mineral powder and Cosmetic composition thereof
KR20140144081A (en) Sunblock cream preparation composition containing one or more of ultraviolet blocking compound
US20090180978A1 (en) Cosmetic composition

Legal Events

Date Code Title Description
AS Assignment

Owner name: GUTHY-RENKER CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SCHLEMER, NATHALIE;DI MARCO, JENNIFER;REEL/FRAME:020017/0625

Effective date: 20070830

AS Assignment

Owner name: UNION BANK OF CALIFORNIA, N.A., AS ADMINISTRATIVE

Free format text: SECURITY AGREEMENT;ASSIGNOR:GUTHY-RENKER LLC;REEL/FRAME:020995/0137

Effective date: 20080505

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION